The porta hepatis as a site of recurrence of mucinous appendiceal neoplasms treated by cytoreductive surgery and perioperative intraperitoneal chemotherapy

Tumori

Volumn 94, Issue 5, 2008, Pages 694-700

  Sugarbaker, Paul H ^a,b   Bijelic, Lana ^a  

^a WASHINGTON CANCER INSTITUTE   (United States)

^b NONE   (United States)

Author keywords

Appendiceal mucinous neoplasm; Biliary obstruction; Cytoreductive surgery; Pseudomyxoma peritonei; Recurrence

Indexed keywords

FLUOROURACIL; MITOMYCIN C;

ADULT; APPENDIX CARCINOMA; ARTICLE; BILE DUCT OBSTRUCTION; BILE DUCT STENT; CANCER LOCALIZATION; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL FEATURE; CYTOREDUCTIVE SURGERY; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; LIVER HILUS; MALE; MUCINOUS CARCINOMA; PERITONEUM METASTASIS; PREOPERATIVE TREATMENT; PROSPECTIVE STUDY; STENT;

EID: 56749091485     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160809400509     Document Type: Article

References (28)

1. Sugarbaker PH, Jablonski KA: Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg, 221: 124-132, 1995.
2. van Ruth S, Acherman YIZ, van de Vijver MJ, Hart AA, Verwaal VJ, Zoetmulder FA: Pseudomyxoma peritonei: a review of 62 cases. Eur J Surg Oncol, 29: 682-688, 2003.
3. Deraco M, Baratti D, Inglese MG, Allaria B, Andreola S, Gavazzi C, Kusamura S: Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei. Ann Surg Oncol, 11: 393-398, 2004.
4. Guner Z, Schmidt U, Dahlke MH, Schlitt HJ, Klempnauer J, Piso P: Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei. Int J Colorectal Dis, 20: 155-160, 2005.
5. Loungnarath R, Causeret S, Bossard N, Faheez M, Sayag-Beaujard AC, Brigand C, Gilly F, Glehen O: Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study. Dis Colon Rectum, 48: 1372-1379, 2005.
6. Murphy EM, Sexton R, Moran BJ: Early results of surgery in 123 patients with pseudomyxoma peritonei from a perforated appendiceal neoplasm. Dis Colon Rectum, 50: 37-42, 2007.
7. Stewart JH IV, Shen P, Russell GB, Bradley RF, Hundley JC, Loggie BL, Geisinger KR, Levine EA: Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy. Ann Surg Oncol, 13: 624-634, 2006.
8. Sugarbaker PH: New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol, 7: 69-76, 2006.
9. Glehen O, Mohamed F, Sugarbaker PH: Incomplete cytoreduction in 174 patients with peritoneal carcinomatosis from appendiceal malignancy. Ann Surg, 240: 278-285, 2004.
10. Yan TD, Bijelic L, Sugarbaker PH: Critical analysis of treatment failure following complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms. Ann Surg Oncol, 14: 2289-2299, 2007.
11. Cunliffe WJ, Sugarbaker PH: Gastrointestinal malignancy: rationale for adjuvant therapy using early postoperative intraperitoneal chemotherapy. Br J Surg, 76: 1082-1090, 1989.
12. Ortega-Perez G, Sugarbaker PH: Right psoas muscle/aortoiliac groove recurrence: an unusual anatomic site for progression of epithelial tumors of the appendix. Int Surg, 87: 212-216, 2002.
13. Liberale G, Elias D, Sideris L, Lasser P, Malka D, Sabourin JC, Pocard M: Inguinal canal as an anatomic sanctuary site of relapse in peritoneal carcinomatosis previously treated with intraperitoneal chemotherapy. J Surg Oncol, 91: 73-76, 2005.
14. Cabanas J, Gomes da Silva R, Goldstein P, Verghese M, Sugarbaker PH: Recurrence of pseudomyxoma peritonei within the inguinal canal. Tumori, 91: 481-486, 2005.
15. Sebbag G, Sugarbaker PH, Walfisch S, Levy I: Chronic perineal fistula as a late failure manifestation of pseudomyxoma peritonei syndrome. Scand J Gastroenterol, 39: 1172-1174, 2004.
16. Cabanas J, Gomes da Silva R, Zappa L, Esquivel J, Cerruto C, Goldstein P, Sugarbaker PH: Splenic metastases from mucinous neoplasms of the appendix and colon. Tumori, 92: 104-112, 2006.
17. Smeenk RM, Verwaal VJ, Antonini N, Zoetmulder FA: Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg, 245: 104-109, 2007.
18. Ronnett BM, Kurman RJ, Shmookler BM, Sugarbaker PH, Young RH: The morphologic spectrum of ovarian metastases of appendiceal adenocarcinomas: A clinicopathologic and immunohistochemical analysis of tumors often misinterpreted as primary ovarian tumors or metastatic tumors from other gastrointestinal sites. Am J Surg Pathol, 21: 1144-1155, 1997.
19. Sugarbaker P: Cytoreduction including total gastrectomy for pseudomyxoma peritonei. Br J Surg, 89: 208-212, 2002.
20. Sugarbaker PH: Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology. Cancer Treat Res, 82: 79-100, 1996.
21. Carmignani CP, Sugarbaker TA, Bromley CM, Sugarbaker PH: Intraperitoneal cancer dissemination: mechanisms of the patterns of spread. Cancer Metastasis Rev, 22: 465-472, 2003.
22. Vazquez Vde L, Sugarbaker PH: Cholecystectomy, lesser omentectomy, and stripping of the omental bursa: a peritonectomy procedure. J Surg Oncol, 84: 45-49, 2003.
23. Sugarbaker PH, Leighton SB: Hepatic parenchymal suction dissector. Surg Gynecol Obstet, 163: 267-269, 1986.
24. Sugarbaker PH: Laser-mode electrosurgery. Cancer Treat Res, 82: 375-385, 1996.
25. Sugarbaker PH, Chang D: Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol, 6: 727-731, 1999.
26. Look M, Chang D, Sugarbaker PH: Long-term results of cytoreductive surgery for advanced and recurrent epithelial ovarian cancers and papillary serous carcinoma of the peritoneum. Int J Gynecol Cancer, 14: 35-41, 2004.
27. Bijelic L, Yan TD, Sugarbaker PH: Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer. Ann Surg Oncol, 14: 2281-2288, 2007.
28. Sugarbaker PH: Peritoneum as the first-line of defense in carcinomatosis. J Surg Oncol, 95: 93-96, 2007.